Multifunctional Drug Treatment in Neurotrauma
- 1 January 2009
- journal article
- review article
- Published by Elsevier BV in Neurotherapeutics
- Vol. 6 (1), 14-27
- https://doi.org/10.1016/j.nurt.2008.10.029
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Roscovitine Reduces Neuronal Loss, Glial Activation, and Neurologic Deficits after Brain TraumaJournal of Cerebral Blood Flow & Metabolism, 2008
- Temporal–spatial expressions of p27kip1 and its phosphorylation on Serine-10 after acute spinal cord injury in adult rat: Implications for post-traumatic glial proliferationNeurochemistry International, 2008
- NeuroprotectionArchives of Neurology, 2007
- Suppression of astroglial scar formation and enhanced axonal regeneration associated with functional recovery in a spinal cord injury rat model by the cell cycle inhibitor olomoucineJournal of Neuroscience Research, 2006
- Involvement of Cell Cycle Elements, Cyclin-dependent Kinases, pRb, and E2F·DP, in B-amyloid-induced Neuronal DeathPublished by Elsevier BV ,1999
- Involvement of CPP32/Caspase-3 in c-Myc-induced apoptosisOncogene, 1998
- Cellular effects of olomoucine, an inhibitor of cyclin‐dependent kinasesBiology of the Cell, 1995
- Comparison of a Serotonin Antagonist, Opioid Antagonist, and TRH Analog for the Acute Treatment of Experimental Spinal TraumaJournal of Neurotrauma, 1991
- Treatment of experimental spinal cord injury with TRH, naloxone, and dexamethasoneSurgical Neurology, 1987
- Thyrotropin-Releasing Hormone Improves Neurologic Recovery after Spinal Trauma in CatsThe New England Journal of Medicine, 1981